Federal contractor profile

CELLPHIRE, INC.

UEI F42VPQJ8LJL4CAGE 48GV8Company website ↗

Active

Small Business

Overview

Legal name: CELLPHIRE, INC.
Also known as: CELLPHIRE
Registered location: ROCKVILLE, MD, USA
Website: Company website ↗
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: Apr 14, 2026

Read company summary

CELLPHIRE, INC. is associated with UEI F42VPQJ8LJL4 and CAGE 48GV8 in public federal records. AcornBids currently links 1 prime award totaling $70.3M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists ROCKVILLE, MD, USA.

At a glance

Lifetime prime obligations$70.3M

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: CELLPHIRE, INC.
Doing business as: CELLPHIRE
UEI: F42VPQJ8LJL4
CAGE: 48GV8
Registered address: 9430 KEY WEST AVE STE 219, ROCKVILLE, MD, 20850, USA
Registration status: Active
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Feb 23, 2026
Initial registration: Dec 22, 2005
Entity start: Dec 2, 2005
SAM updated: Feb 23, 2026
Registration expires: Feb 19, 2027
Fiscal year end: Dec 31
Place of incorporation: DE, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
W81XWH20C0030CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE	Department of Defense	$70.3M	Dec 20, 2019	Oct 31, 2028

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE

Department of Defense$70.3M obligationsEnds Oct 31, 202860% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Feb 23, 2026
Source loaded	Sep 26, 2026
Initial registration	Dec 22, 2005
Entity start	Dec 2, 2005

Registration classifications: Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
ED COLES	Government business	Contact method not published	SAM registration	Not available
SARA AIRASIAN	Alternate government business	Contact method not published	SAM registration	Not available
KRISTA DAVIS	Electronic business	Contact method not published	SAM registration	Not available
SARA AIRASIAN	Alternate electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source